e 64 has been researched along with dactinomycin in 1 studies
Studies (e 64) | Trials (e 64) | Recent Studies (post-2010) (e 64) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
477 | 1 | 103 | 19,045 | 355 | 969 |
Protein | Taxonomy | e 64 (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for e 64 and dactinomycin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |